BIOCHEMICAL INTERACTIONS BETWEEN N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (FU)

被引：0
|
作者：
LIANG, CM [1 ]
DONEHOWER, RC [1 ]
ERLICHMAN, C [1 ]
CHABNER, BA [1 ]
机构：
[1] NIH,BETHESDA,MD 20205
来源：
FEDERATION PROCEEDINGS | 1980年 / 39卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1909 / 1909
页数：1
相关论文
共 50 条
  • [31] SYNERGISTIC EFFECT OF 5-FLUOROURACIL AND N-(PHOSPHONACETYL)-L-ASPARTATE ON CELL-GROWTH AND RIBONUCLEIC-ACID SYNTHESIS IN A HUMAN MAMMARY-CARCINOMA
    ARDALAN, B
    GLAZER, RI
    KENSLER, TW
    JAYARAM, HN
    VANPHAM, T
    MACDONALD, JS
    COONEY, DA
    BIOCHEMICAL PHARMACOLOGY, 1981, 30 (15) : 2045 - 2049
  • [32] MODULATION OF HUMAN OVARIAN TUMOR-CELL SENSITIVITY TO N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) BY LIPOSOME DRUG CARRIERS
    SHARMA, A
    STRAUBINGER, NL
    STRAUBINGER, RM
    PHARMACEUTICAL RESEARCH, 1993, 10 (10) : 1434 - 1441
  • [33] Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer
    Fleming, RA
    Capizzi, RL
    Muss, HB
    Smith, S
    Fernandes, DJ
    Homesley, H
    Loggie, BW
    Case, LD
    Morris, R
    Russell, GB
    Richards, F
    CLINICAL CANCER RESEARCH, 1996, 2 (07) : 1107 - 1114
  • [34] PHASE-I TRIAL OF N-PHOSPHONACETYL-L-ASPARTATE (PALA), METHOTREXATE (MTX), 5-FLUOROURACIL (FU), AND LEUCOVORIN (LV) IN ADVANCED COLORECTAL-CANCER (CRC)
    KEMENY, N
    REICHMAN, B
    GORDON, C
    ELLISON, S
    DEONARINE, S
    SLAVIK, B
    MARTIN, D
    YOUNG, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 187 - 187
  • [35] A NEW SYNDROME - ASCITES, HYPERBILIRUBINEMIA, AND HYPOALBUMINEMIA AFTER BIOCHEMICAL MODULATION OF FLUOROURACIL WITH N-PHOSPHONACETYL-L-ASPARTATE (PALA)
    KEMENY, N
    SEITER, K
    MARTIN, D
    URMACHER, C
    NIEDZWIECKI, D
    KURTZ, RC
    COSTA, P
    MURRAY, M
    ANNALS OF INTERNAL MEDICINE, 1991, 115 (12) : 946 - 951
  • [36] SERUM URIDINE LEVELS IN PATIENTS RECEIVING N-(PHOSPHONACETYL)-L-ASPARTATE
    KARLE, JM
    ANDERSON, LW
    ERLICHMAN, C
    CYSYK, RL
    CANCER RESEARCH, 1980, 40 (08) : 2938 - 2940
  • [37] LONG-TERM ASSOCIATION OF N-(PHOSPHONACETYL)-L-ASPARTATE WITH BONE
    ARDALAN, B
    KENSLER, TW
    JAYARAM, HN
    MORRISON, W
    CHOIE, DD
    CHADWICK, M
    LISS, R
    COONEY, DA
    CANCER RESEARCH, 1981, 41 (01) : 150 - 156
  • [38] 2.5 A STRUCTURE OF ASPARTATE CARBAMOYLTRANSFERASE COMPLEXED WITH THE BISUBSTRATE ANALOG N-(PHOSPHONACETYL)-L-ASPARTATE
    KRAUSE, KL
    VOLZ, KW
    LIPSCOMB, WN
    JOURNAL OF MOLECULAR BIOLOGY, 1987, 193 (03) : 527 - 553
  • [39] BIOCHEMICAL ASPECTS OF CHEMOTHERAPY OF MOUSE NEOPLASMS WITH N-PHOSPHONACETYL-L-ASPARTATE (PALA)
    BROCKMAN, RW
    ROSE, LM
    SHADDIX, SC
    DUBOIS, NF
    SCHABEL, FM
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1693 - 1693
  • [40] A PHASE-I STUDY OF CONTINUOUS-INFUSION 5-FLUOROURACIL PLUS CALCIUM LEUCOVORIN IN COMBINATION WITH N-(PHOSPHONACETYL)-L-ASPARTATE IN METASTATIC GASTROINTESTINAL ADENOCARCINOMA
    GREM, JL
    MCATEE, N
    STEINBERG, SM
    HAMILTON, JM
    MURPHY, RF
    DRAKE, J
    CHISENA, T
    BALIS, F
    CYSYK, R
    ARBUCK, SG
    SORENSEN, JM
    CHEN, AP
    GOLDSTEIN, L
    JORDAN, E
    SETSER, A
    GOLDSPIEL, B
    DECARVALHO, M
    ALLEGRA, CJ
    CANCER RESEARCH, 1993, 53 (20) : 4828 - 4836
12345